<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>eightk.txt
<DESCRIPTION>FORM 8-K
<TEXT>
                        UNITED STATES
             SECURITIES AND EXCHANGE COMMISSION
                    WASHINGTON, DC 20549


                          FORM 8-K


                       CURRENT REPORT
           Pursuant to Section 13 or 15(d) of the
               Securities Exchange Act of 1934

 Date of report (Date of earliest event reported):
                 October 6, 2006

                      JOHNSON & JOHNSON
   (Exact name of registrant as specified in its charter)

     New Jersey             1-3215        22-1024240
(State or Other Juris- (Commission File  (IRS Employer
diction of Incorporation)   Number)    Identification No.)

One Johnson & Johnson Plaza, New Brunswick, New Jersey 08933
     (Address of Principal Executive Offices) (Zip Code)

Registrant's telephone number, including area code:
                       732-524-0400

      Check the appropriate box below if the Form 8-K filing
is  intended to simultaneously satisfy the filing obligation
of the registrant under any of the following provisions:

     [  ]  Written communications pursuant to Rule 425 under
     the Securities Act (17 CFR 230.425)

     [  ]  Soliciting material pursuant to Rule 14a-12 under
     the Exchange Act (17 CFR 240.14a-12)

     [   ]  Pre-commencement communications pursuant to Rule
     14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     [   ]  Pre-commencement communications pursuant to Rule
     13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item  5.02.   Departure of Directors or Principal  Officers;
Election of Directors; Appointment of Principal Officers.

     On  October 6, 2006, the Company issued a press release
announcing  that  Robert  J. Darretta,  the  Company's  Vice
Chairman  of  the  Board of Directors  and  Chief  Financial
Officer,  has elected to retire in early 2007.  The  Company
also announced that Dominic J. Caruso, Vice President of the
Company's  Group  Finance organization, has  been  appointed
Corporate   Vice  President,  Finance  and  Chief  Financial
Officer, effective January 1, 2007.  Mr. Caruso will  report
to  William  C.  Weldon, the Company's  Chairman  and  Chief
Executive  Officer,  and become a member  of  the  Company's
Executive Committee.

     Mr.  Caruso,  49, has led the Company's  Group  Finance
organization since December 2005. Previously,  he  was  Vice
President,  Group  Finance  for  the  Medical  Devices   and
Diagnostics  (MD&D) Group and a member  of  the  MD&D  Group
Operating  Committee.   In  2001,  Mr.  Caruso  became  Vice
President, Finance for Ortho-McNeil Pharmaceutical, Inc. and
a  member of its Management Board, before being named to the
MD&D  position  in  May 2003.  Mr. Caruso joined  Johnson  &
Johnson in October 1999 through the acquisition of Centocor,
Inc. where he was Vice President, Finance.

     A  copy of the press release is attached as Exhibit  99
to this report.


                         SIGNATURES

     Pursuant to the requirements of the Securities Exchange
Act  of 1934, the registrant has duly caused this report  to
be  signed  on  its behalf by the undersigned hereunto  duly
authorized.

                              JOHNSON & JOHNSON
                              (Registrant)

Date:  October  12, 2006      By: /s/ Steven M. Rosenberg
                                     Steven M. Rosenberg
                                     Secretary



                        EXHIBIT INDEX

Exhibit No.    Description

99             Press release dated October 6, 2006.
</TEXT>
</DOCUMENT>